UniProt ID | PARK7_HUMAN | |
---|---|---|
UniProt AC | Q99497 | |
Protein Name | Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309} | |
Gene Name | PARK7 {ECO:0000312|HGNC:HGNC:16369} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 189 | |
Subcellular Localization |
Cell membrane Lipid-anchor . Cytoplasm . Nucleus . Membrane raft . Mitochondrion . Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subs |
|
Protein Description | Protein and nucleotide deglycase that catalyzes the deglycation of the Maillard adducts formed between amino groups of proteins or nucleotides and reactive carbonyl groups of glyoxals. [PubMed: 25416785] | |
Protein Sequence | MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASKRALVI ------CCCCCEEEE | 24.61 | 25944712 | |
17 | Sulfoxidation | LAKGAEEMETVIPVD EECCHHHHCCEEEHH | 3.83 | 21406390 | |
19 | Phosphorylation | KGAEEMETVIPVDVM CCHHHHCCEEEHHHH | 23.56 | 21406692 | |
26 | Sulfoxidation | TVIPVDVMRRAGIKV CEEEHHHHHHCCCEE | 1.76 | 16517609 | |
27 | Methylation | VIPVDVMRRAGIKVT EEEHHHHHHCCCEEE | 25.75 | - | |
32 | Acetylation | VMRRAGIKVTVAGLA HHHHCCCEEEEECCC | 30.82 | 25953088 | |
32 | Malonylation | VMRRAGIKVTVAGLA HHHHCCCEEEEECCC | 30.82 | 26320211 | |
32 | Ubiquitination | VMRRAGIKVTVAGLA HHHHCCCEEEEECCC | 30.82 | - | |
41 | Ubiquitination | TVAGLAGKDPVQCSR EEECCCCCCCCCCCC | 53.93 | 21890473 | |
41 | Acetylation | TVAGLAGKDPVQCSR EEECCCCCCCCCCCC | 53.93 | 26051181 | |
41 | Malonylation | TVAGLAGKDPVQCSR EEECCCCCCCCCCCC | 53.93 | 26320211 | |
41 | 2-Hydroxyisobutyrylation | TVAGLAGKDPVQCSR EEECCCCCCCCCCCC | 53.93 | - | |
46 | S-palmitoylation | AGKDPVQCSRDVVIC CCCCCCCCCCCEEEC | 3.52 | 23847046 | |
46 | S-nitrosylation | AGKDPVQCSRDVVIC CCCCCCCCCCCEEEC | 3.52 | 24105792 | |
46 | Glutathionylation | AGKDPVQCSRDVVIC CCCCCCCCCCCEEEC | 3.52 | 22555962 | |
47 | Phosphorylation | GKDPVQCSRDVVICP CCCCCCCCCCEEECC | 17.90 | 29507054 | |
53 | S-palmitoylation | CSRDVVICPDASLED CCCCEEECCCCCHHH | 1.36 | 23847046 | |
53 | S-nitrosylation | CSRDVVICPDASLED CCCCEEECCCCCHHH | 1.36 | 19483679 | |
53 | Glutathionylation | CSRDVVICPDASLED CCCCEEECCCCCHHH | 1.36 | 22555962 | |
53 | S-nitrosocysteine | CSRDVVICPDASLED CCCCEEECCCCCHHH | 1.36 | - | |
57 | Phosphorylation | VVICPDASLEDAKKE EEECCCCCHHHHHHH | 39.41 | 26552605 | |
62 | 2-Hydroxyisobutyrylation | DASLEDAKKEGPYDV CCCHHHHHHHCCCCE | 64.77 | - | |
62 | Acetylation | DASLEDAKKEGPYDV CCCHHHHHHHCCCCE | 64.77 | 25953088 | |
62 | Ubiquitination | DASLEDAKKEGPYDV CCCHHHHHHHCCCCE | 64.77 | - | |
63 | Acetylation | ASLEDAKKEGPYDVV CCHHHHHHHCCCCEE | 70.40 | 25038526 | |
63 | Ubiquitination | ASLEDAKKEGPYDVV CCHHHHHHHCCCCEE | 70.40 | - | |
67 | Phosphorylation | DAKKEGPYDVVVLPG HHHHHCCCCEEEECC | 32.02 | 28796482 | |
83 | Phosphorylation | NLGAQNLSESAAVKE CCCCCCCCHHHHHHH | 36.73 | 21712546 | |
85 | Phosphorylation | GAQNLSESAAVKEIL CCCCCCHHHHHHHHH | 20.39 | 21712546 | |
89 | Succinylation | LSESAAVKEILKEQE CCHHHHHHHHHHHHH | 34.02 | 23954790 | |
89 | Ubiquitination | LSESAAVKEILKEQE CCHHHHHHHHHHHHH | 34.02 | - | |
93 | Acetylation | AAVKEILKEQENRKG HHHHHHHHHHHHHCC | 64.11 | 25953088 | |
93 | Succinylation | AAVKEILKEQENRKG HHHHHHHHHHHHHCC | 64.11 | 23954790 | |
93 | Ubiquitination | AAVKEILKEQENRKG HHHHHHHHHHHHHCC | 64.11 | - | |
93 | 2-Hydroxyisobutyrylation | AAVKEILKEQENRKG HHHHHHHHHHHHHCC | 64.11 | - | |
99 | Ubiquitination | LKEQENRKGLIAAIC HHHHHHHCCHHHHHH | 70.43 | - | |
106 | Cysteine sulfinic acid (-SO2H) | KGLIAAICAGPTALL CCHHHHHHCCHHHHH | 2.84 | - | |
106 | Oxidation | KGLIAAICAGPTALL CCHHHHHHCCHHHHH | 2.84 | 12939276 | |
106 | S-palmitoylation | KGLIAAICAGPTALL CCHHHHHHCCHHHHH | 2.84 | 29575903 | |
130 | 2-Hydroxyisobutyrylation | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | - | |
130 | Ubiquitination | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | - | |
130 | Sumoylation | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | 15976810 | |
130 | Succinylation | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | 23954790 | |
130 | Sumoylation | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | - | |
130 | Acetylation | VTTHPLAKDKMMNGG CCCCCCCCCCCCCCC | 66.61 | 23749302 | |
132 | 2-Hydroxyisobutyrylation | THPLAKDKMMNGGHY CCCCCCCCCCCCCCC | 39.06 | - | |
132 | Acetylation | THPLAKDKMMNGGHY CCCCCCCCCCCCCCC | 39.06 | 23954790 | |
133 | Sulfoxidation | HPLAKDKMMNGGHYT CCCCCCCCCCCCCCC | 3.46 | 16517609 | |
134 | Sulfoxidation | PLAKDKMMNGGHYTY CCCCCCCCCCCCCCC | 5.33 | 16517609 | |
139 | Phosphorylation | KMMNGGHYTYSENRV CCCCCCCCCCCCCCE | 15.62 | 21945579 | |
140 | Phosphorylation | MMNGGHYTYSENRVE CCCCCCCCCCCCCEE | 18.20 | 21945579 | |
141 | Phosphorylation | MNGGHYTYSENRVEK CCCCCCCCCCCCEEE | 13.56 | 21945579 | |
142 | Phosphorylation | NGGHYTYSENRVEKD CCCCCCCCCCCEEEC | 22.16 | 21945579 | |
148 | Succinylation | YSENRVEKDGLILTS CCCCCEEECEEEEEE | 54.99 | 27452117 | |
148 | 2-Hydroxyisobutyrylation | YSENRVEKDGLILTS CCCCCEEECEEEEEE | 54.99 | - | |
148 | Acetylation | YSENRVEKDGLILTS CCCCCEEECEEEEEE | 54.99 | 23954790 | |
148 | Ubiquitination | YSENRVEKDGLILTS CCCCCEEECEEEEEE | 54.99 | 21890473 | |
154 | Phosphorylation | EKDGLILTSRGPGTS EECEEEEEECCCCCC | 14.91 | 21815630 | |
155 | Phosphorylation | KDGLILTSRGPGTSF ECEEEEEECCCCCCH | 31.62 | 21712546 | |
175 | Ubiquitination | IVEALNGKEVAAQVK HHHHHCCCHHEEEEE | 48.19 | - | |
182 | Succinylation | KEVAAQVKAPLVLKD CHHEEEEECCEEECC | 32.01 | 23954790 | |
182 | Malonylation | KEVAAQVKAPLVLKD CHHEEEEECCEEECC | 32.01 | 32601280 | |
182 | Ubiquitination | KEVAAQVKAPLVLKD CHHEEEEECCEEECC | 32.01 | - | |
182 | Succinylation | KEVAAQVKAPLVLKD CHHEEEEECCEEECC | 32.01 | - | |
182 | Acetylation | KEVAAQVKAPLVLKD CHHEEEEECCEEECC | 32.01 | 25953088 | |
188 | 2-Hydroxyisobutyrylation | VKAPLVLKD------ EECCEEECC------ | 54.64 | - | |
188 | Ubiquitination | VKAPLVLKD------ EECCEEECC------ | 54.64 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
154 | T | Phosphorylation | Kinase | PKACA | P17612 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:15525661 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF6 | Q9Y4K3 | PMID:20634198 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
130 | K | Sumoylation |
| 12851414 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PARK7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
606324 | Parkinson disease 7 (PARK7) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-67, AND MASSSPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Proper SUMO-1 conjugation is essential to DJ-1 to exert its fullactivities."; Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,Seino C., Iguchi-Ariga S.M.M., Ariga H.; Cell Death Differ. 13:96-108(2006). Cited for: SUMOYLATION AT LYS-130, OXIDATION, SUBCELLULAR LOCATION, INDUCTION,AND FUNCTION. |